Results 61 to 70 of about 3,249 (159)

Supplementary Material – The effect of AS1411 surface density on the tumor targeting properties of PEGylated silver nanotriangles

open access: yes, 2022
Figure 1. XRD pattern of AgNTs. XRD: X-ray diffraction; AgNTs: silver nanotriangles. Figure 2. FTIR spectra of Chitosan, AgNTs, PNTs, 0.5-ANTs, 1-ANTs, 5-ANTs, 10-ANTs and 15-ANTs. FTIR: Fourier transform infrared.
Jing Ma (24574)   +6 more
core   +1 more source

Introduction of a Double‐Headed Nucleotide Into G‐Quadruplex DNA: Position‐Dependent Stabilization and Structural Insights

open access: yesChemistry – A European Journal, Volume 32, Issue 41, 3 November 2026.
A double‐headed bis‐guanine (G) nucleotide (GG) was evaluated as a noncanonical building block in G‐quadruplexes (G4s). Biophysical and computational analyses reveal that GG can directly participate in G‐tetrads and strongly stabilize G4s in a position‐ and topology‐dependent manner. These findings establish design rules for using GG to engineer highly
Krista Urup   +5 more
wiley   +1 more source

Targeted Protein Degradation: From Molecular Mechanisms to Emerging Therapeutic Strategies

open access: yesMedComm, Volume 7, Issue 11, November 2026.
Graphical overview of targeted protein degradation: mechanisms, molecular determinants, delivery strategies, and therapeutic development. This graphical abstract summarizes the major degradation pathways involved in targeted protein degradation, including the ubiquitin–proteasome system, endocytosis–lysosome pathway, and autophagy‐dependent degradation.
Huaijuan Guo   +8 more
wiley   +1 more source

Nucleolin Alterations and ROS Production Associate With Sensitivity of AML Cells to Venetoclax

open access: yesThe FASEB Journal, Volume 40, Issue 19, 15 October 2026.
Venetoclax‐induced Bcl‐2 inhibition corresponds with Mcl‐1 attenuation and decrease of Nucleolin (NCL) level and activity in sensitive cells. Simultaneously, distinct cell subpopulations with opposite mitochondrial (CellROX label, magenta) and cellular (H2DCFDA stain, green) ROS occur, and the H2DCFDA‐positive population shows markers of early ...
Kateřina Wolfová   +2 more
wiley   +1 more source

Abstract 4450: A new paradigm for AS1411 activity: Uptake by macropinocytosis and induction of macropinocytosis by a nucleolin-dependent mechanism

open access: yes, 2010
AS1411 is an experimental drug that is currently in Phase II clinical trials as a novel therapy for cancer. It is a G-rich phosphodiester oligodeoxynucleotide, which forms a stable quadruplex structure and binds specifically to nucleolin as an aptamer ...
Elsa M. Reyes-Reyes, Paula J. Bates
core   +1 more source

From Molecular Targets to Advanced Delivery Systems: Aptamers for Precision Ocular Therapeutics

open access: yesAdvanced Therapeutics, Volume 9, Issue 10, October 2026.
Aptamer‐based strategies are revolutionizing ocular disease management through highly specific molecular recognition of disease specific molecular targets. This review systematically integrates therapeutic aptamer sequences, diagnostic aptasensor platforms, and targeted delivery strategies, highlighting design principles, ocular bioavailability ...
Minal Thacker   +4 more
wiley   +1 more source

Binding affinity of AS1411 towards HCC cell lines and tissues.

open access: yes, 2015
(a) Nucleolin is detected on cell surface of Huh7 (left) but not on Hu767 (primary hepatocyte, right). 1 million cells of each cell line were incubated with 2ug/ml Nucleolin Antibody and 1ug/ml secondary antibody of mouse-FITC for 1h at 4°C, which was ...
Chen Liu (75209)   +7 more
core   +1 more source

Supramolecular Degraders: An Emerging Paradigm in Targeted Protein Degradation

open access: yesAdvanced Science, Volume 13, Issue 58, 19 October 2026.
Dynamic supramolecular assembly reshapes targeted protein degradation by coordinating modular degrader construction, delivery, functional integration, and intracellular assembly or activation across proteasomal, endosomal–lysosomal, and autophagy–lysosomal pathways.
Kongjun Liu   +8 more
wiley   +1 more source

The Bioactivity of D-/L-Isonucleoside- and 2′-Deoxyinosine-Incorporated Aptamer AS1411s Including DNA Replication/MicroRNA Expression

open access: yesMolecular Therapy: Nucleic Acids, 2017
In this study, chemical modification of 2′-deoxyinosine (2′-dI) and D-/L-isothymidine (D-/L-isoT) was performed on AS1411. They could promote the nucleotide-protein interaction by changing the local conformation.
Xinmeng Fan   +11 more
doaj   +1 more source

In vivo evaluation of AS1411-Dox adduct in Huh7 tumor xenograft mouse model.

open access: yes, 2015
(a) Mice treated with free Dox or AS1411-Dox adduct had significant lower rates of tumor growth than those treated with AS1411 or control DNA-Dox adduct.
Chen Liu (75209)   +7 more
core   +1 more source

Home - About - Disclaimer - Privacy